PMC:7321036 / 54731-54985
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T430 | 73-81 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T282 | 20-28 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T283 | 31-40 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T284 | 232-240 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T731 | 127-128 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T408 | 46-50 | http://purl.obolibrary.org/obo/GO_0004707 | denotes | MAPK |
| T409 | 73-92 | http://purl.obolibrary.org/obo/GO_0001816 | denotes | cytokine production |
| T410 | 106-123 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
| T411 | 106-123 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
| T412 | 174-178 | http://purl.obolibrary.org/obo/GO_0004707 | denotes | MAPK |
| T413 | 241-253 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1209 | 42-50 | Gene | denotes | p38/MAPK | Gene:5594 |
| 1210 | 170-173 | Gene | denotes | p38 | Gene:5594 |
| 1222 | 20-40 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
| 1223 | 232-240 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T357 | 0-254 | Sentence | denotes | In contrast, during SARS-CoV-2 infection, p38/MAPK inhibition suppressed cytokine production and impaired viral replication by a still unknown mechanism, suggesting that p38/MAPK inhibition may target multiple mechanisms related to COVID-19 pathogenesis. |